Efficacy of anti-PD-1/PD-L1 plus chemotherapy in treatment-naïve advanced HER2-negative gastric adenocarcinoma among different PD-L1 intervals: an updated meta-analysis and reconstructed individual patient-level data analysis
- DOI
- 10.1186/s12916-026-05124-z
- Published
- 2026-08-08
- Container
- BMC Medicine
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12916-026-05124-z,
title = {Efficacy of anti-PD-1/PD-L1 plus chemotherapy in treatment-naïve advanced HER2-negative gastric adenocarcinoma among different PD-L1 intervals: an updated meta-analysis and reconstructed individual patient-level data analysis},
author = {Yu-Kun Chen and Wen-Wei Wu and Fan Chen and Lan-Jie Chen and Hao-Xiang Wu and Ying-Nan Wang and Ying Jin and Yu-Tong Chen and Zi-Xian Wang},
year = {2026},
journal = {BMC Medicine},
doi = {10.1186/s12916-026-05124-z},
url = {https://doi.org/10.1186/s12916-026-05124-z}
}RIS
TY - JOUR TI - Efficacy of anti-PD-1/PD-L1 plus chemotherapy in treatment-naïve advanced HER2-negative gastric adenocarcinoma among different PD-L1 intervals: an updated meta-analysis and reconstructed individual patient-level data analysis AU - Yu-Kun Chen AU - Wen-Wei Wu AU - Fan Chen AU - Lan-Jie Chen AU - Hao-Xiang Wu AU - Ying-Nan Wang AU - Ying Jin AU - Yu-Tong Chen AU - Zi-Xian Wang PY - 2026 JO - BMC Medicine DO - 10.1186/s12916-026-05124-z UR - https://doi.org/10.1186/s12916-026-05124-z ER -
APA
Chen, Y., Wu, W., Chen, F., Chen, L., Wu, H., Wang, Y., Jin, Y., Chen, Y., & Wang, Z. (2026). Efficacy of anti-PD-1/PD-L1 plus chemotherapy in treatment-naïve advanced HER2-negative gastric adenocarcinoma among different PD-L1 intervals: an updated meta-analysis and reconstructed individual patient-level data analysis. BMC Medicine. https://doi.org/10.1186/s12916-026-05124-z
Source records
- crossref · retrieved 2026-11-07T22:26:00.535Z